Ncs2* mediates in vivo virulence of pathogenic yeast through sulphur modification of cytoplasmic transfer RNA.
Fiona AlingsKarin ScharmannCristian EggersBettina BöttcherMikołaj SokołowskiEkaterina ShvetsovaPuneet SharmaJoël RothLeon RashitiSebastian GlattSascha BrunkeSebastian Andreas LeidelPublished in: Nucleic acids research (2023)
Fungal pathogens threaten ecosystems and human health. Understanding the molecular basis of their virulence is key to develop new treatment strategies. Here, we characterize NCS2*, a point mutation identified in a clinical baker's yeast isolate. Ncs2 is essential for 2-thiolation of tRNA and the NCS2* mutation leads to increased thiolation at body temperature. NCS2* yeast exhibits enhanced fitness when grown at elevated temperatures or when exposed to oxidative stress, inhibition of nutrient signalling, and cell-wall stress. Importantly, Ncs2* alters the interaction and stability of the thiolase complex likely mediated by nucleotide binding. The absence of 2-thiolation abrogates the in vivo virulence of pathogenic baker's yeast in infected mice. Finally, hypomodification triggers changes in colony morphology and hyphae formation in the common commensal pathogen Candida albicans resulting in decreased virulence in a human cell culture model. These findings demonstrate that 2-thiolation of tRNA acts as a key mediator of fungal virulence and reveal new mechanistic insights into the function of the highly conserved tRNA-thiolase complex.
Keyphrases
- cell wall
- biofilm formation
- candida albicans
- antimicrobial resistance
- pseudomonas aeruginosa
- escherichia coli
- staphylococcus aureus
- human health
- oxidative stress
- saccharomyces cerevisiae
- climate change
- cystic fibrosis
- dna damage
- physical activity
- transcription factor
- type diabetes
- gene expression
- dna methylation
- genome wide
- adipose tissue
- metabolic syndrome
- induced pluripotent stem cells
- heat shock protein